Latest News & Updates
Breaking News
1 minute ago
Vaibhavi M.
Other trending news you may like to read
Thermo Fisher Launches Global CorEvitas Alzheimer’s Registry With First Patient Enrolled, Advances Real-World Evidence In Alzheimers
Thermo Fisher launches a global Alzheimer’s registry to collect regulator-ready real-world data on safety, effectiveness, and care patterns.
Vaibhavi M.
Salarius Announces Name And Ticker Change Following Decoy Therapeutics Combination; Adopting New NASDAQ Ticker DCOY
Salarius announces rebrand to Decoy Therapeutics, signaling a shift toward peptide-conjugate therapies in antivirals and oncology.
Vaibhavi M.
Novo Nordisk Files FDA Application For Dual Amylin–GLP-1 Obesity Therapy CagriSema; For Chronic Weight Management
Novo Nordisk files FDA NDA for CagriSema, a first-in-class GLP-1 and amylin injectable for long-term weight loss and maintenance.
Vaibhavi M.
Nxera Regains Full Rights To GPR52 Schizophrenia Program After Boehringer Ingelheim Declines Option; Nxera To Seek New Partner For Phase 2–Ready GPR52 Agonist
Nxera resumes full control of its Phase 2–ready GPR52 agonist NXE’149 for schizophrenia and plans new partnering discussions.
Vaibhavi M.
